Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.8K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

357
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
357
Mutations01:39

Mutations

88.2K
Overview
88.2K
Mutations01:35

Mutations

41.6K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
41.6K
Mismatch Repair01:20

Mismatch Repair

5.6K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.6K
Mismatch Repair01:36

Mismatch Repair

41.8K
Overview
41.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones.

Cancer research·2026
Same author

The emergence and molecular evolution of H5N1 influenza viruses in United States dairy cattle.

bioRxiv : the preprint server for biology·2026
Same author

Mutant p53 Directs PARP to Regulate Replication Stress and Drive Breast Cancer Metastasis.

bioRxiv : the preprint server for biology·2026
Same author

Correction: p53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities.

Molecular cancer research : MCR·2026
Same author

Protection Against <i>Salmonella</i> by Vaccination with Toxin-Antitoxin Self-Destructive Bacteria.

Vaccines·2026
Same author

Detection of Two High Pathogenicity Avian Influenza Virus (HPAIV) Subtypes, H5N1 and H5N5, in a Mass Mortality Event in Wild Seabirds and Co-Location With Dead Seals.

Transboundary and emerging diseases·2026
Same journal

ERG orchestrates a dedifferentiation-senescence-inflammation triad in prostate cancer.

Molecular cancer research : MCR·2026
Same journal

Comprehensive multi-omic profiling of desmoplastic small round cell tumors identifies targetable pathways with therapeutic opportunities.

Molecular cancer research : MCR·2026
Same journal

CELF2 is a tumor suppressor that modulates SLC7A11 and promotes ferroptosis in stomach adenocarcinoma.

Molecular cancer research : MCR·2026
Same journal

MYC-Mediated USP39 Upregulation Stabilizes SRSF1 in Pancreatic Cancer.

Molecular cancer research : MCR·2026
Same journal

Ceramide-induced endoplasmic reticulum stress reveals a targetable vulnerability in endocrine therapy-resistant breast cancer.

Molecular cancer research : MCR·2026
Same journal

Mapping the Subtype-Specific PARP1 ADP-ribosylated Proteome in Breast Cancer Cells.

Molecular cancer research : MCR·2026
See all related articles

Related Experiment Video

Updated: Nov 4, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.8K

p53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities.

David R Tong1, Wen Zhou1, Chen Katz1

  • 1Department of Biological Sciences, Columbia University, New York, New York.

Molecular Cancer Research : MCR
|May 28, 2021
PubMed
Summary
This summary is machine-generated.

p53 frameshift mutants, often found in cancer, show altered functions. One mutant retains some antiproliferative activity and induces senescence, offering potential therapeutic targets.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.9K
Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts
10:04

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts

Published on: January 8, 2017

7.4K

Related Experiment Videos

Last Updated: Nov 4, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.8K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.9K
Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts
10:04

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts

Published on: January 8, 2017

7.4K

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • p53 mutations are common in cancer, often leading to loss of transcriptional activity.
  • Frameshift mutations in the TP53 gene can produce truncated p53 proteins with altered properties.

Purpose of the Study:

  • To characterize p53 frameshift mutant proteins expressed from endogenous TP53 locus.
  • To investigate the functional consequences of these mutants in cancer cell lines.

Main Methods:

  • Analysis of p53 frameshift mutants in U2OS osteosarcoma and HCT116 colorectal cancer cell lines.
  • Assessment of DNA-binding, oligomerization, transcriptional activity, and cellular functions (proliferation, senescence, migration).

Main Results:

  • Three p53 frameshift mutants were characterized, retaining intact DNA-binding domains but showing altered oligomerization.
  • Mutants were transcriptionally inactive, unable to initiate wild-type p53 programs.
  • One mutant, I332fs*14, exhibited residual antiproliferative activity, induced senescence, and decreased cell motility.

Conclusions:

  • p53 frameshift mutants display a mix of loss-of-gain and gain-of-function characteristics.
  • These variants differ from both wild-type p53 and complete p53 loss.
  • The residual and neomorphic functions of p53 frameshift mutants may be targets for novel cancer therapies.